Best 510(k) Regulatory Services: Compare Scope, Fees, and Fit

Last reviewed August 24, 2026. FDA fees, provider scope and prices can change; confirm the current engagement terms before purchasing.

Quick verdict

510(k) regulatory services comparison

Price note: The $17,500 figure is a provider-published estimate for preparation, not a total program budget. Testing, clinical work, standards purchases, FDA fees, establishment registration and post-clearance work can be separate. A quote is not comparable until those boundaries are explicit.

Start with the free FDA checks

1. Classify the device. Search FDA’s Product Classification database for the product code, regulation number, device class and exemption status.
2. Check the exemption limitations. Most Class I and some Class II devices are exempt, but the section .9 limitations in 21 CFR Parts 862–892 can restore the 510(k) requirement.
3. Check predicates. Search the 510(k) database for legally marketed devices with a defensible intended-use and technology comparison.
4. Separate clearance from registration and listing. A 510(k) decision does not replace establishment registration, device listing or other post-clearance duties. See FURLS registration and device listing.
5. Decide whether formal FDA feedback is worth it. A voluntary Pre-Submission can help resolve focused questions before testing or filing, but FDA says it is not a pre-review and does not guarantee a favorable later decision.

For a fuller pathway check, use our planned guide to when a 510(k) is required versus exempt.

Budget the FDA fee separately

Small-business pricing is not automatic. The submitter needs an FDA Small Business Decision number for the relevant fiscal year before the submission is received. FDA says it will not refund the difference later if a reduced fee was not properly claimed.

eSTAR, technical screening and the review clock

Most 510(k) submissions have been required to use FDA’s eSTAR template since October 1, 2023. For CDRH, FDA’s current eSTAR page says 510(k) and De Novo submissions must be sent through the CDRH Portal.

FDA says a properly prepared eSTAR is not anticipated to undergo the traditional Refuse to Accept review. It still receives virus scanning and technical screening. An incomplete eSTAR can be placed on hold, and FDA may close it if a complete replacement is not received within 180 days of the technical-screening deficiency notice.

Do not buy a “90 calendar day” guarantee. FDA’s goal is a MDUFA decision within 90 FDA days. Days when the submission is on hold for an Additional Information request are excluded, and preparation before filing is outside that clock.

Ordinary consultant or FDA-recognized third-party reviewer?

An ordinary consultant can help classify the device, plan evidence, draft eSTAR and manage communications. That does not make the firm an FDA-recognized 3P510k Review Organization.

The Third Party Review Program is a voluntary alternative for eligible product codes. The accredited organization performs the primary review using FDA criteria and sends a recommendation to FDA; FDA still makes the final decision. FDA charges no separate 510(k) user fee for this route, but the submitter pays the review organization under a private agreement.

The list above reflects FDA’s database update of August 17, 2026. Eligibility is limited by product code and by each organization’s recognized scope. Check FDA’s live list before contracting because recognition and eligibility can change.

What every 510(k) quote should state

1. Pathway and predicate work: classification, product code, regulatory strategy and predicate analysis.
2. Evidence plan: bench, biocompatibility, electrical safety, software, cybersecurity, usability, sterilization, shelf-life and clinical work, as applicable.
3. Submission deliverable: eSTAR authorship, attachments, quality review and CDRH Portal upload responsibility.
4. FDA interactions: official correspondent role, interactive-review support and Additional Information responses.
5. Money: fixed fee or hourly cap, testing and laboratory charges, FDA user fee, travel, change orders and refund or cancellation terms.
6. Ownership: the manufacturer or other legal holder should be unmistakably identified. A consultant’s drafting role does not transfer FDA clearance ownership unless a lawful transaction and records support it.

Red flags before you sign

• “FDA 510(k) approval.” FDA clears a 510(k) after finding substantial equivalence; it does not approve the device through this pathway.
• Guaranteed clearance or a guaranteed timeline. A consultant cannot control FDA’s decision, evidence gaps or hold time.
• “FDA-accredited” without a match in FDA’s current 3P510k list.
• A low headline price with no testing, FDA-response or user-fee boundaries.
• No device-specific experience check. Ask for recent work involving your product code, technology and evidence type—not a generic clearance count.
• No written ownership, confidentiality or change-order terms.

If a marketplace triggered the problem

A marketplace document request is different from deciding whether to file a new 510(k). Start with Amazon medical-device 510(k) restrictions or TikTok Shop 510(k) and FURLS requirements before paying someone to create a submission you may not need.

Need to compare evidence and quotes without taking a provider’s marketing at face value? Read how we verify prices, our methodology, editorial policy and affiliate disclosure.

Limitations and disclaimer

This comparison uses public information available on August 24, 2026. A provider’s published scope is not proof that it is right for a particular device, and the absence of a public price is not evidence of a higher or lower quote. FDA fees change by fiscal year; provider scope, staffing and terms can change; and FDA can revise or withdraw third-party recognition. We did not test these services as customers. This page does not guarantee FDA clearance, any timeline or acceptance by a marketplace. It is informational only and is not legal or regulatory advice.